Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients
2023-08
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients
Authors
Published Date
2023-08
Publisher
Type
Thesis or Dissertation
Abstract
This master’s thesis focuses on the work completed during my K01 award Genetic Variants Associated with Tacrolimus (TAC) metabolism in Kidney Transplant Recipients. In Chapter 1, I discuss the significance and innovations of this project. In Chapter 2, I present reformatted manuscript published in the Pharmacogenomics Journal titled: Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing. In Chapter 3, I present a reformatted manuscript published in Drug Metabolism and Disposition titled: CRISPR/Cas9 genetic modification of CYP3A5 *3 in human hepatocytes leads to cell lines with increased midazolam and tacrolimus metabolism. Chapter 4 is the general conclusions, future directions and take away messages.
Keywords
Description
University of Minnesota M.S. thesis. August 2023. Major: Biomedical Informatics and Computational Biology. Advisor: Ajay Israni. 1 computer file (PDF); viii, 93 pages.
Related to
Replaces
License
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Other identifiers
Suggested citation
Dorr, Casey. (2023). Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/259530.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.